Pneumatic Nebulizers Market Size, Share & Trends Analysis Report By Product (Breath-actuated, Vented), By End-use (Hospitals & Clinics, Home Healthcare), By Region (North America, APAC), And Segment Forecasts, 2021 - 2028

Report Overview

The global pneumatic nebulizers market size was valued at USD 644.34 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.0% over the forecast period. The increasing incidence of chronic respiratory diseases, demand for home healthcare devices, and growing geriatric population are the factors expected to drive the market. According to statistics published by the CDC, approximately 18.4 million adults in the U.S. suffer from asthma. The COVID-19 pandemic has impacted all industries, including the pneumatic nebulizers market. Asthma or COPD patients, who were aware of the risk of airborne transmission of COVID-19, were hesitant about the use of inhaled medications, which are considered as a potential source of viral transmission and immunosuppression.

However, medical practitioners advised all such patients to continue using their prescribed inhaled medications, including nebulizers. Therefore, the overall impact of COVID-19 on the market was minimal. Easy availability of compact pneumatic nebulizers ideal for home use, and technological innovations in these devices to reduce the sound created by them & improve their functionality, are increasing their adoption in-home healthcare. Moreover, these devices are favored by third-party payers, such as insurance companies, as they aim to reduce costs while providing quality healthcare services. These factors are expected to boost the adoption over the forecast period.

Product Insights

The breath-actuated product segment held the largest revenue share of over 64% in 2020. The breath-actuated nebulizers elucidate higher drug delivery capacity and lesser dosage wastage features. Thus, the segment, delivering advanced inhalation therapy, is expected to dominate the market over the forecast period. Affordability and easy integration of vented type of pneumatic nebulizer has driven its demand. Key players are focusing on developing innovative products. For instance, Ventec Life Systems received (510(k) clearance) U.S. FDA approval for VOCSN in April 2017. The device is a portable life support system, which delivers five respiratory therapies including nebulization, oxygen, cough, suction, and ventilation.

End-use Insights

The hospitals & clinics segment dominated the market in 2020, accounting for a revenue share of more than 66%. Hospitals are an integral part of the healthcare sector and a major revenue source for the entire industry. Therefore, multiple companies invest substantial efforts, both in terms of marketing strategies and revenue, to endorse their product/services among hospitals.

Over the recent years, home healthcare devices have been gaining popularity, thereby driving the segment growth. The easy availability of compact nebulizers ideal for home use and technological innovations to improve functionality are also increasing their adoption in-home healthcare. Moreover, the rising geriatric population and the need to curb healthcare expenditure are anticipated to boost the adoption of home healthcare devices.

Regional Insights

North America accounted for the largest revenue share of more than 35.0% in 2020. According to the American Lung Association (ALA), there may be around 24 million American adults suffering from COPD. Moreover, the rise in the geriatric population in the U.S. is leading to a corresponding growth in the number of surgeries in the country, which further boosts the regional market growth. China accounted for the largest revenue share of the Asia Pacific regional market.

A significant rise in the geriatric population in Japan is driving the product demand in the country, thereby supporting regional growth. The burden of COPD in Asia is greater than that in developed Western countries. In Japan, 90% of patients with COPD reported a strong history of smoking. Moreover, countries such as India and China are also predicted to have a significant population suffering from pulmonary diseases.

Key Companies & Share Insights

The global market is fairly competitive. The most notable participants in the market are Koninklijke Philips N.V. and Omron Corp. Key players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, in January 2020, OMRON Corp. announced the opening of the Automation Center Tokyo (ATC-TOKYO) in Tokyo. With this center, customers can join the company to find solutions for any challenges arising during production. Some of the prominent players in the global pneumatic nebulizers market include:

• Koninklijke Philips N.V.

• Omron Corp.

• PARI Pharma

• General Electric Company

• Allied Healthcare Products, Inc.

• BD (Becton, Dickinson & Company)

• GF Health Products, Inc.

• Medline Industries, Inc.

• Briggs Healthcare

• Vectura Group Plc

Pneumatic Nebulizers Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global pneumatic nebulizers market report on the basis of product, end-use, and region:

• Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Breath-actuated

  • Vented

• End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals & Clinics

  • Home Healthcare

• Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa

    • Saudi Arabia